TickerFacts.

Myriad Genetics Inc (MYGN): Operating Cash Flow

Annual figures by period end, from SEC filings.

$1.80M
Year ended 2025-12-31
$7.70M
Trailing 12 months to 2026-06-30
$173.87M2009-06-30: $84.04M2010-06-30: $155.09M2011-06-30: $130.83M2012-06-30: $141.80M2013-06-30: $173.87M2016-06-30: $166.30M2017-06-30: $106.20M2018-06-30: $115.90M2019-06-30: $83.70M2020-06-30: $60.70M2021-12-31: $18.60M2022-12-31: -$106.30M2023-12-31: -$110.90M2024-12-31: -$8.70M2025-12-31: $1.80M$1.80M
2009-06-30 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$1.80Mn/m2026-02-24, From 2025-01-01
2024-12-31-$8.70Mn/m2026-02-24, From 2024-01-01
2023-12-31-$110.90Mn/m2026-02-24, From 2023-01-01
2022-12-31-$106.30Mn/m2025-02-28, From 2022-01-01
2021-12-31$18.60Mn/a2024-02-28, From 2021-01-01
No annual figure between 2020-06-30 and 2021-12-31.
2020-06-30$60.70M-27.5%2023-03-01, From 2019-07-01
2019-06-30$83.70M-27.8%2022-02-25, From 2018-07-01
2018-06-30$115.90M+9.1%2020-08-13, From 2017-07-01
2017-06-30$106.20M-36.1%2019-08-13, From 2016-07-01
2016-06-30$166.30Mn/a2018-08-24, From 2015-07-01
No annual figure between 2013-06-30 and 2016-06-30.
2013-06-30$173.87M+22.6%2013-08-14, From 2012-07-01
2012-06-30$141.80M+8.4%2013-08-14, From 2011-07-01
2011-06-30$130.83M-15.6%2013-08-14, From 2010-07-01
2010-06-30$155.09M+84.5%2012-08-15, From 2009-07-01
2009-06-30$84.04Mn/a2011-08-15, From 2008-07-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Myriad Genetics Inc (MYGN)2025-12-31$1.80Mn/m
Neogen Corp (NEOG)2026-05-31$83.20M+43.0%
Lantheus Holdings, Inc. (LNTH)2025-12-31$390.14M-28.4%
QuidelOrtho Corp (QDEL)2025-12-28$105.20M+26.7%
Idexx Laboratories Inc (IDXX)2025-12-31$1.18B+27.2%
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$394.74Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$8.65Mn/m
Immucell Corp (ICCC)2025-12-31$2.48M+591.6%
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.03Mn/m

Compare MYGN, NEOG, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗